Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PerkinElmer, ViaCell deal

PKI plans to acquire cord blood banking company VIAC for $7.25 per share,

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE